Benzinga | Apr 26, 2021 01:00PM EDT

Roth Capital Maintains Buy on Sharps Compliance, Raises Price Target to $18

Roth Capital analyst Gerry Sweeney maintains Sharps Compliance (NASDAQ:SMED) with a Buy and raises the price target from $16 to $18.